首页> 外文期刊>Middle East African Journal of Ophthalmology >Molecular Pathology of Retinoblastoma
【24h】

Molecular Pathology of Retinoblastoma

机译:视网膜母细胞瘤的分子病理学

获取原文
       

摘要

Retinoblastoma (RB) is an embryonic neoplasm of retinal origin. For many years, scientists have sought the fundamental origins of tumorigenesis, with the ultimate hope of discovering a cure. Indeed, these efforts have led to a significant understanding that multiple molecular and genetic aberrations, such as uncontrolled proliferation and the inhibition of apoptosis that contribute to the canonical characteristics of tumor biology. Despite these advances, a thorough understanding, such as the precise cells, which are the targets of neoplastic transformation, especially in solid tumors, is currently lacking. The focus of this review is to emphasize the molecular defects involved in the RB tumor progression and mechanisms associated with inhibition of tumor cell apoptotic processes. This review also discusses the importance of target molecules characterization and their potential therapeutic or prognostic use in RB disease.Keywords: Pathology, Proteomics, Retinoblastoma, Target Therapy
机译:视网膜母细胞瘤(RB)是视网膜起源的胚胎肿瘤。多年来,科学家一直在寻找肿瘤发生的根本原因,并最终找到了治愈的希望。确实,这些努力已导致人们对多种分子和遗传畸变(例如不受控制的增殖和细胞凋亡的抑制)产生了深刻的理解,这些畸变是肿瘤生物学的典型特征。尽管取得了这些进展,但目前仍缺乏透彻的了解,例如精确细胞,它们是肿瘤转化的靶标,尤其是在实体瘤中。该综述的重点是强调与RB肿瘤进展有关的分子缺陷以及与抑制肿瘤细胞凋亡过程相关的机制。这篇综述还讨论了靶分子表征在RB疾病中的重要性及其在RB疾病中的潜在治疗或预后用途。关键词:病理学,蛋白质组学,视网膜母细胞瘤,靶标治疗

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号